SCHEMBL7447295

SCHEMBL7447295

c1ccc(N2CCCO2)nc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLD1 Q13393 1/20 0.44
KDM4E B2RXH2 4/20 0.44
ALDH1A1 P00352 5/20 0.42
HSD17B10 Q99714 3/20 0.42
HPGD P15428 2/20 0.42
GRIN2D O15399 1/20 0.41
GRIN3B O60391 1/20 0.41
GRIN1 Q05586 1/20 0.41
GRIN2A Q12879 1/20 0.41
GRIN2B Q13224 1/20 0.41
GRIN2C Q14957 1/20 0.41
GRIN3A Q8TCU5 1/20 0.41
HTT P42858 2/20 0.40
CRBN Q96SW2 1/20 0.39
ALOX5 P09917 1/20 0.39
MEN1 O00255 2/20 0.38
USP2 O75604 2/20 0.38
CYP3A4 P08684 2/20 0.38
CYP2D6 P10635 2/20 0.38
CYP2C9 P11712 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL30547521 0.85 DPP4 (0.43) KDM4EALDH1A1HSD17B10HPGDHTT
SCHEMBL5314104 0.70 PLD1 (0.49) PLD1KDM4EALDH1A1HSD17B10HPGD
SCHEMBL29462629 0.70 PLD1 (0.68) PLD1KDM4EALDH1A1HSD17B10HPGD
SCHEMBL363383 0.70 LMNA (0.45) KDM4EALDH1A1HSD17B10ALOX5MEN1
SCHEMBL157489 0.70 PLD1 (0.68) PLD1KDM4EALDH1A1HSD17B10HPGD
SCHEMBL230367 0.70 PLD1 (0.68) PLD1KDM4EALDH1A1HSD17B10HPGD
SCHEMBL18228078 0.70 PLD1 (0.68) PLD1KDM4EALDH1A1HSD17B10HPGD
SCHEMBL22326 0.69 ALDH1A1 (0.69) PLD1KDM4EALDH1A1HSD17B10HPGD
SCHEMBL29390734 0.69 ALDH1A1 (0.69) PLD1KDM4EALDH1A1HSD17B10HPGD
SCHEMBL21353591 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 119 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240208962-A1 MICROBIOCIDAL QUINOLINE/QUINOXALINE BENZOTHIAZINE DERIVATIVES SYNGENTA CROP PROTECTION AG (CH) 2024-06-27 US disclosed
US-12012399-B2 Microbiocidal quinoline dihydro-(thiazine)oxazine derivatives SYNGENTA PARTICIPATIONS AG (CH) 2024-06-18 US disclosed
EP-4326710-A1 MICROBIOCIDAL QUINOLINE/QUINOXALINE ISOQUINOLINE DERIVATIVES Syngenta Crop Protection AG (CH) 2024-02-28 EP disclosed
EP-4132924-B1 MICROBIOCIDAL QUINOLINE DIHYDRO-(THIAZINE)OXAZINE DERIVATIVES SYNGENTA CROP PROTECTION AG (CH) 2024-02-21 EP disclosed
EP-4132926-B1 MICROBIOCIDAL QUINOLINE DIHYDRO-(THIAZINE)OXAZINE DERIVATIVES SYNGENTA CROP PROTECTION AG (CH) 2024-02-21 EP disclosed
EP-4312556-A1 MICROBIOCIDAL QUINOLINE/QUINOXALINE BENZOTHIAZINE DERIVATIVES Syngenta Crop Protection AG (CH) 2024-02-07 EP disclosed
CN-117241668-A Microbiocidal quinoline/quinoxaline benzothiazine derivatives 先正达农作物保护股份公司 2023-12-15 CN disclosed
CN-117177963-A Microbiocidal quinoline/quinoxaline isoquinoline derivatives 先正达农作物保护股份公司 2023-12-05 CN disclosed
US-11744246-B2 Preparation of mammalian oocyte for fertilization via a soluble human PH20 hyaluronidase polypeptide SYNGENTA PARTICIPATIONS AG (CH) 2023-09-05 US disclosed
WO-2023111215-A1 MICROBIOCIDAL PYRIDINE-SUBSTITUTED BENZOTHIAZINE DERIVATIVES SYNGENTA CROP PROTECTION AG (CH) 2023-06-22 WO disclosed
WO-2017029289-A1 1-HYDROXY-3H-2,1-BENZOXABOROLE DERIVATIVES AND THEIR USE AS MICROBIOCIDES SYNGENTA PARTICIPATIONS AG (CH) 2017-02-23 WO disclosed
WO-2016113313-A1 NOVEL MICROBIOCIDES SYNGENTA PARTICIPATIONS AG (CH) 2016-07-21 WO disclosed
WO-2016113303-A1 MICROBIOCIDAL BENZOXABOROLES SYNGENTA PARTICIPATIONS AG (CH) 2016-07-21 WO disclosed
WO-2016071239-A1 NOVEL FUNGICIDAL PYRIDYLAMIDINES SYNGENTA PARTICIPATIONS AG (CH) 2016-05-12 WO disclosed
WO-2016016118-A1 MICROBIOCIDAL IMIDAZOLE DERIVATIVES SYNGENTA PARTICIPATIONS AG (CH) 2016-02-04 WO disclosed
WO-2015162268-A1 MICROBIOCIDAL IMIDAZOLE DERIVATIVES SYNGENTA PARTICIPATIONS AG (CH) 2015-10-29 WO disclosed
WO-2015162271-A1 MICROBIOCIDAL IMIDAZOLE DERIVATIVES SYNGENTA PARTICIPATIONS AG (CH) 2015-10-29 WO disclosed
WO-2015162269-A1 MICROBIOCIDAL IMIDAZOLE DERIVATIVES SYNGENTA PARTICIPATIONS AG (CH) 2015-10-29 WO disclosed
US-5330994-A Antidepressants, anxiolytic agents WARNER-LAMBERT COMPANY (US) 1994-07-19 US disclosed
WO-1993019062-A1 TETRAHYDROPYRIDINE ISOXAZOLINE DERIVATIVES WARNER-LAMBERT COMPANY (US) 1993-09-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12012399-B2 Microbiocidal quinoline dihydro-(thiazine)oxazine derivatives TLR1, TLR5, IDO1 PLD1 620/4885KDM4E 2885/4885ALDH1A1 312/4885
US-20240208962-A1 MICROBIOCIDAL QUINOLINE/QUINOXALINE BENZOTHIAZINE DERIVATIVES IFNG, IRF3, MAVS PLD1 768/4885KDM4E 1541/4885ALDH1A1 1076/4885
US-11744246-B2 Preparation of mammalian oocyte for fertilization via a soluble human PH20 hyaluronidase polypeptide PHF20, FUCA1, ZP1 PLD1 536/4885KDM4E 4050/4885ALDH1A1 1241/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.